SPONSOR
Jiangsu Simcere Pharmaceutical Co., Ltd.
Total Trials
4
Recruiting
4
Phases
Phase 1
Conditions studied: Neoplasms, MalignantLocally Advanced Solid TumorsAdvanced Solid TumorsAdvanced Solid TumoursNon-Small Cell Lung CancerColorectal CancerHead and Neck Squamous Cell CarcinomaHepatocellular Carcinoma
Jiangsu Simcere Pharmaceutical Co., Ltd. is a clinical research sponsor with 4 registered studies on ClinicalTrials.gov, of which 4 are actively recruiting participants. Research covers conditions including Neoplasms, Malignant, Locally Advanced Solid Tumors, Advanced Solid Tumors, Advanced Solid Tumours.
The trial portfolio spans Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Jiangsu Simcere Pharmaceutical Co., Ltd.
How many clinical trials has Jiangsu Simcere Pharmaceutical Co., Ltd. sponsored?
ClinicalMetric currently tracks 4 clinical trials sponsored by Jiangsu Simcere Pharmaceutical Co., Ltd., of which 4 are actively recruiting participants. These trials cover conditions including Neoplasms, Malignant, Locally Advanced Solid Tumors, Advanced Solid Tumors. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Jiangsu Simcere Pharmaceutical Co., Ltd. research focus on?
Jiangsu Simcere Pharmaceutical Co., Ltd. clinical trials span Neoplasms, Malignant, Locally Advanced Solid Tumors, Advanced Solid Tumors, Advanced Solid Tumours, Non-Small Cell Lung Cancer, and additional conditions. The research pipeline includes Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Jiangsu Simcere Pharmaceutical Co., Ltd. clinical trial?
To participate in a Jiangsu Simcere Pharmaceutical Co., Ltd. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Jiangsu Simcere Pharmaceutical Co., Ltd. trials with current recruitment status updated daily.
Clinical Trials by Jiangsu Simcere Pharmaceutical Co., Ltd.
NCT07660432 Phase 1
Recruiting
A Study of SIM0689 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
Neoplasms, Malignant
NCT07050459 Phase 1
Recruiting
A Phase I Study of SIM0686 in Participants With Locally Advanced/Metastatic Solid Tumors
Locally Advanced Solid Tumors
NCT06686745 Phase 1
Recruiting
Study of SIM0508 Alone and in Combination in Patients With Advanced Solid Tumors
Advanced Solid Tumors
NCT07348211 Phase 1
Recruiting
First in Human Study of SIM0610 in Solid Tumors
Advanced Solid Tumours
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology